Antifungal therapeutic drug monitoring: established and emerging indications
D Andes, A Pascual, O Marchetti - Antimicrobial agents and …, 2009 - Am Soc Microbiol
The successful management of invasive fungal infections continues to pose a difficult
challenge to clinicians. As the population of at-risk immunocompromised patients increases …
challenge to clinicians. As the population of at-risk immunocompromised patients increases …
Approaches to the management of invasive fungal infections in hematologic malignancy and hematopoietic cell transplantation
M Michallet, JI Ito - Journal of clinical oncology, 2009 - ascopubs.org
Patients with hematologic malignancy and hematopoietic cell transplant (HCT) recipients
are at increased risk for invasive fungal infection (IFI) as a result of immunosuppression or …
are at increased risk for invasive fungal infection (IFI) as a result of immunosuppression or …
Drug interaction between oral solution itraconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplantation recipients: an association with …
T Mori, Y Aisa, J Kato, Y Nakamura, Y Ikeda… - International journal of …, 2009 - Springer
To assess the drug interaction between oral solution itraconazole and calcineurin inhibitors,
10 recipients of allogeneic hematopoietic stem cell transplantation (HSCT), in whom oral …
10 recipients of allogeneic hematopoietic stem cell transplantation (HSCT), in whom oral …
Itraconazole: comprehensive profile
AA Al-Badr, HI El-Subbagh - Profiles of drug substances, excipients and …, 2009 - Elsevier
Publisher Summary This chapter describes itraconazole, its nomenclature, formula, physical
characteristics, methods of chemical synthesis and analysis, stability, pharmacokinetics …
characteristics, methods of chemical synthesis and analysis, stability, pharmacokinetics …